Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:receptor_tyrosine_kinase
gptkb:drug |
| gptkbp:administeredBy |
oral
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
L01EB02
|
| gptkbp:brand |
gptkb:Tarceva
|
| gptkbp:CASNumber |
183321-74-6
|
| gptkbp:developedBy |
gptkb:OSI_Pharmaceuticals
|
| gptkbp:discoveredIn |
1990s
|
| gptkbp:hasMolecularFormula |
C22H23N3O4
|
| https://www.w3.org/2000/01/rdf-schema#label |
OSI-774
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits EGFR tyrosine kinase
|
| gptkbp:sideEffect |
diarrhea
anorexia fatigue rash |
| gptkbp:synonym |
gptkb:Erlotinib
|
| gptkbp:target |
gptkb:epidermal_growth_factor_receptor
|
| gptkbp:usedFor |
gptkb:non-small_cell_lung_cancer
pancreatic cancer |
| gptkbp:bfsParent |
gptkb:Erlotinib
|
| gptkbp:bfsLayer |
7
|